The role of prostatitis in prostate cancer: Meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Jiang, Junyi ^a   Li, Jinyi ^b   Zhang, Yunxia ^c   Zhu, Hong ^a   Liu, Junjiang ^c   Pumill, Chris ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HEBEI GENERAL HOSPITAL   (China)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE-CONTROL STUDIES; HUMANS; INTERVIEWS AS TOPIC; MALE; MODELS, STATISTICAL; ODDS RATIO; PREVALENCE; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 84894049683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085179     Document Type: Article

References (41)

1. Ohshima H, Bartsch H (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253-264. doi:10.1016/0027-5107(94)90245-3. PubMed: 7510036. (Pubitemid 24082901)
2. Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: G515-G520. doi:10.1152/ajpgi.00475.2003. PubMed: 15010360. (Pubitemid 38374969)
3. Terzic J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138: 2101-2114 e2105
4. Matysiak-Budnik T, Mégraud F (2006) Helicobacter pylori infection and gastric cancer. Eur J Cancer 42: 708-716. doi:10.1016/j.ejca.2006.01.020. PubMed: 16556496.
5. Forte V, Pandey A, Abdelmessih R, Forte G, Whaley-Connell A et al. (2012) Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med 2: 143-162. doi:10.1159/000337314. PubMed: 22851963.
6. Dítì P, Hermanová M, Trna J, Novotný I, Růžička M et al. (2012) The role of chronic inflammation: chronic pancreatitis as a risk factor of pancreatic cancer. Dig Dis 30: 277-283. doi:10.1159/000336991. PubMed: 22722552.
7. Lonkar P, Dedon PC (2011) Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 128: 1999-2009. doi:10.1002/ijc.25815. PubMed: 21387284.
8. Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31: 37-49. doi:10.1093/carcin/bgp272. PubMed: 19955394.
9. Demaria M, Poli V (2012) Pro-malignant properties of STAT3 during chronic inflammation. Oncotarget 3: 359-360. PubMed: 22535863.
10. Bollrath J, Greten FR (2009) IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep 10: 1314-1319. doi:10.1038/embor.2009.243. PubMed: 19893576.
11. Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE et al. (2003) Organochlorines and risk of prostate cancer. J Occup Environ Med 45: 692-702. doi:10.1097/01.jom.0000071510.96740.0b. PubMed: 12855910. (Pubitemid 36875646)
12. Rao Tunuguntla Gurunadha, HS, Evans CP (2002) Management of prostatitis. Prostate Cancer Prostatic Dis 5: 172-179. doi:10.1038/sj.pcan.4500604. PubMed: 12496977.
13. Sharp VJ, Takacs EB, Powell CR (2010) Prostatitis: diagnosis and treatment. Am Fam Physician 82: 397-406. PubMed: 20704171.
14. Gregorio DI, Samociuk H, DeChello L, Swede H (2006) Effects of study area size on geographic characterizations of health events: prostate cancer incidence in Southern New England, USA, 1994-1998. Int J Health Geogr 5: 8. doi:10.1186/1476-072X-5-8. PubMed: 16480512.
15. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y (2008) Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer 123: 430-435. doi:10.1002/ijc.23500. PubMed: 18452170. (Pubitemid 351842030)
16. Ku JH, Kim SW, Paick JS (2005) Epidemiologic risk factors for chronic prostatitis. Int J Androl 28: 317-327. doi:10.1111/j.1365-2605.2005.00560.x. PubMed: 16300663. (Pubitemid 41719753)
17. Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4: 221-233. doi:10.1158/1541-7786.MCR-05-0261. PubMed: 16603636.
18. Dennis LK, Lynch CF, Torner JC (2002) Epidemiologic association between prostatitis and prostate cancer. Urology 60: 78-83. doi:10.1016/S0090-4295(02) 01637-0. PubMed: 12100928. (Pubitemid 34722951)
19. Nickel JC, Nyberg LM, Hennenfent M (1999) Research guidelines for chronic prostatitis: consensus report from the First National Institutes of Health International Prostatitis Collaborative Network. Urology 54: 229-233. doi:10.1016/S0090-4295(99)00205-8. PubMed: 10443716. (Pubitemid 29367243)
20. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ (2004) Prostatitis as a risk factor for prostate cancer. Epidemiology 15: 93-99. doi:10.1097/00001648-200407000-00233. PubMed: 14712152. (Pubitemid 40417002)
21. Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R et al. (2008) Evaluation of prostatitis in autopsied prostates - is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 179: 1736-1740. doi:10.1016/j.juro.2008.01.034. PubMed: 18343414.
22. Rosenblatt KA, Wicklund KG, Stanford JL (2001) Sexual factors and the risk of prostate cancer. Am J Epidemiol 153: 1152-1158. doi:10.1093/aje/153.12. 1152. PubMed: 11415949. (Pubitemid 32552272)
23. Daniels NA, Chen YH, Bent S (2009) Antibiotic and anti-inflammatory use and the risk of prostate cancer. BMC Res Notes 2: 57. doi:10.1186/1756-0500-2- 57. PubMed: 19374749.
24. Hiatt RA, Armstrong MA, Klatsky AL, Sidney S (1994) Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 5: 66-72. doi:10.1007/BF01830728. PubMed: 7510134. (Pubitemid 24066595)
25. Lee MM, Wang RT, Hsing AW, Gu FL, Wang T et al. (1998) Casecontrol study of diet and prostate cancer in China. Cancer Causes Control 9: 545-552. doi:10.1023/A:1008840105531. PubMed: 10189039. (Pubitemid 29046126)
26. Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS (1999) Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol 28: 409-417. doi: 10.1093/ije/28.3.409. PubMed: 10405842. (Pubitemid 29276698)
27. Fernández L, Galán Y, Jiménez R, Gutiérrez A, Guerra M et al. (2005) Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba. Int J Epidemiol 34: 193-197. PubMed: 15375086. (Pubitemid 40347393)
28. Hsing AW, Wang RT, Gu FL, Lee M, Wang T et al. (1994) Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 3: 285-288. PubMed: 8061575. (Pubitemid 24181571)
29. Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA et al. (2006) Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol 176: 1108-1113. doi:10.1016/j.juro.2006.04. 075. PubMed: 16890703. (Pubitemid 44142574)
30. Pelucchi C, Talamini R, Negri E, Franceschi S, La Vecchia C (2006) Genital and urinary tract diseases and prostate cancer risk. Eur J Cancer Prev 15: 254-257. doi:10.1097/01.cej.0000198897.40303.d4. PubMed: 16679869. (Pubitemid 43791772)
31. Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY et al. (2005) Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan. Cancer Causes Control 16: 263-273. doi:10.1007/s10552-004-3486-6. PubMed: 15947878. (Pubitemid 40897845)
32. Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ et al. (2007) Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 16: 1573-1580. doi:10.1158/1055-9965. EPI-07-0134. PubMed: 17684131. (Pubitemid 47294821)
33. Rothman I, Stanford JL, Kuniyuki A, Berger RE (2004) Self-report of prostatitis and its risk factors in a random sample of middle-aged men. Urology 64: 876-880; discussion:
34. Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK et al. (2010) Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control 21: 117-125. doi:10.1007/s10552-009-9441- 9. PubMed: 19816779.
35. Huang WY, Hayes R, Pfeiffer R, Viscidi RP, Lee FK et al. (2008) Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17: 2374-2381. doi:10.1158/1055-9965.EPI-08-0173. PubMed: 18768506.
36. John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG et al. (1995) Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst 87: 662-669. doi:10.1093/jnci/87.9.662. PubMed: 7538594.
37. Wright JL, Lin DW, Stanford JL (2012) Circumcision and the risk of prostate cancer. Cancer 118: 4437-4443. doi:10.1002/cncr.26653. PubMed: 22411189.
38. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA et al. (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 20: 2551-2559. doi:10.1158/1055-9965.EPI-11-0777. PubMed: 22109347.
39. Chao C, Haque R, Van Den Eeden SK, Caan BJ, Poon KY et al. (2010) Red wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer 126: 171-179. doi:10.1002/ijc.24637. PubMed: 19521962.
40. Schiller DS, Parikh A (2011) Identification, pharmacologic considerations, and management of prostatitis. Am J Geriatr Pharmacother 9: 37-48. doi:10.1016/j.amjopharm.2011.02.005. PubMed: 21459307.
41. Magri V, Perletti G, Bartoletti R, Cai T, Emelyanova I et al. (2010) Critical issues in chronic prostatitis. Arch Ital Urol Androl 82: 75-82. PubMed: 20812529.